Number of the records: 1
Complementary genetic screens identify the E3 ubiquitin ligase CBLC, as a modifier of PARP inhibitor sensitivity
- 1.FRANKUM, J., MOUDRÝ, P., BROUGH, R., HODNÝ, Z., ASHWORTH, A., BÁRTEK, J., LORD, C.J. Complementary genetic screens identify the E3 ubiquitin ligase CBLC, as a modifier of PARP inhibitor sensitivity. OncoTarget. 2015, 6(13), 10746-10758. ISSN 1949-2553. Available: doi: 10.18632/oncotarget.3628
Number of the records: 1